Sort
23,748 grants matching “melanoma”
Integrated analyses of genetics, epigenetics, and gene expression
$1,142,960Maxwell Lee · Division Of Basic Sciences - Nci · ZIH · FY2021 · CA
MODIFICATION OF HYPERTHERMIA RESPONSE
$1,141,941Thomas Jefferson University · P01 · FY2001 · CA
DCTD Human Toxicology and Pharmacology
$1,141,659David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2015 · CA
Advancing a Glioma Immunotherapy
$1,139,204Dwaine Franklin Emerich · In Cytu, Inc. · R44 · FY2014 · NS
NIA Confocal Imaging Facility
$1,138,060Fred Indig · National Institute On Aging · ZIC · FY2019 · AG
Rewired Signaling at the Nexus of Melanoma Metastasis and Resistance
$1,137,453Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R35 · FY2017 · CA
Rewired Signaling at the Nexus of Melanoma Metastasis and Resistance
$1,135,587Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R35 · FY2018 · CA
Computational Molecular Pathology Research for Cancer Diagnostics and Biomarkers
$1,135,325Robert Simpson · Division Of Basic Sciences - Nci · ZIC · FY2020 · CA
Animal Model and Genotyping Core Support Facility
$1,133,495Glenn T. Merlino · Division Of Basic Sciences - Nci · ZIC · FY2017 · CA
DCTD Functional Genomics
$1,133,280David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2011 · CA
Clinical production of viral vectors for cancer gene therapy
$1,131,975Rachel Beyer · Division Of Basic Sciences - Nci · ZIC · FY2024 · CA
Multi-Center Study of Pancreatic Cancer Etiology
$1,131,891John D Potter · Kaiser Foundation Health Plan Of Washington · R01 · FY2007 · CA
Rewired Signaling at the Nexus of Melanoma Metastasis and Resistance
$1,131,504Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R35 · FY2020 · CA
Bioinformatics
$1,130,592Leping Li · National Institute Of Environmental Health Sciences · ZIA · FY2014 · ES
Rewired Signaling at the Nexus of Melanoma Metastasis and Resistance
$1,129,373Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R35 · FY2021 · CA
Vaccines and Therapeutics for Anthrax
$1,128,820Stephen Leppla · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Engineering and Imaging 3D genome structure-function dynamics across time scales
$1,128,347Jennifer Elizabeth Phillips-Cremins · University Of Pennsylvania · U01 · FY2021 · DK
Preclinical development of Ala+TIMP-2 as an cancer therapeutic
$1,128,123William Stetler-Stevenson · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
DCTD Human Toxicology and Pharmacology
$1,127,454David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2016 · CA
A Phase 1 Clinical Trial Evaluating the Novel Small Molecule Immuno-Oncology Antagonist SX-682 Alone and With Pembrolizumab in Metastatic Melanoma
$1,125,311Stuart J Kahn · Syntrix Biosystems, Inc. · R44 · FY2018 · CA
Pilot Project Program
$1,124,951Raymond E Samuel · Hampton University · U54 · FY2015 · MD
MODIFICATION OF HYPERTHERMIA RESPONSE
$1,124,047Thomas Jefferson University · P01 · FY2000 · CA
Proteogenomic studies to understand mechanisms and drivers of resistance to immunotherapies
$1,122,409Amanda G Paulovich · Fred Hutchinson Cancer Center · U01 · FY2024 · CA
Surgery Branch Cell Prep Core
$1,122,261John Wunderlich · Division Of Basic Sciences - Nci · ZIC · FY2020 · CA
Cell Production Core Facility
$1,122,261John Wunderlich · Division Of Basic Sciences - Nci · ZIC · FY2020 · CA